NSE ScannerOpen the scanner

Pharmaceuticals · Pharmaceuticals: Major · NSE: KOPRAN · data 2026-10-30

Kopran Limited

₹239.05-5.14% on 30 OctHealth: Average 5.4/10
Feb 2026Low ₹108.04 · High ₹290.9+70.7%

In plain words

Price: 19.2% below its 52-week high of ₹295.83.

Delivery: 40.7% of traded shares were kept for delivery over the last 10 sessions, against 39.0% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹239.05
Market cap
₹1,215 cr
P/E
46.2
P/B
—
ROE
4.9%
ROCE
10.1%
Debt / equity
0.29
Dividend yield
1.19%
1-year return
43.2%
52-week high
₹295.83
52-week low
₹107
Operating margin
8.7%

Growth

Revenue (last 12 months)₹700 cr
Net profit (last 12 months)₹25 cr
Sales growth, 3 years (yearly)7.2%
Profit growth, 3 years (yearly)-1.9%

Smart-money activity

15/100 · Weak over the last ~60 sessions, data 2026-10-30

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

2026-09-15: Bulk deal: IRAGE BROKING SERVICES LLP bought ₹1.3 cr2026-09-07: Bulk deal: UNITED SHIPPERS LTD sold ₹11.73 cr2026-08-11: Dividend ₹3 (ex-date)

● Deal   ● Dividend

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Kopran Limited debt-free?

Its latest reported debt-to-equity ratio is 0.29.

What is Kopran Limited's P/E ratio?

About 46.2, based on the last 12 months' earnings and a price of ₹239.05 (data 2026-10-30).

What is the 52-week high and low of Kopran Limited?

The 52-week high is ₹295.83 and the 52-week low is ₹107.

Similar companies

Anlon Healthcare Limited (AHCL) · Bharat Parenterals Ltd. (BPLPHARMA) · Bafna Pharmaceuticals Limited (BAFNAPH) · Bajaj Healthcare Ltd (BAJAJHCARE) · Remus Pharmaceuticals Ltd. (REMUS)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open KOPRAN in NSE Scanner →
Share on WhatsAppShare on Telegram